Answers are grounded in this paper and cite their sources.
Nanozymes have emerged as promising alternatives or complementary catalysts to natural enzymes in electrochemical sensing owing to their high catalytic activity, tunable structures, and excellent stability. This review focuses on their applications in drug analysis, highlighting recent advances in nanozyme-enabled electrochemical sensing strategies for pharmaceutical detection. It first covers nanozyme types, catalytic mechanisms, and differences from natural enzymes. Sensor construction strategies are then discussed, including surface functionalization, interface optimization, and multifunctional integration. Applications are summarized by drug class, including anticancer agents, cardiovascular drugs, antibiotics, narcotic drugs and controlled substances. Existing research indicates that nanozymes improve detection sensitivity and selectivity, and some platforms have already demonstrated the potential for on-site or real-time monitoring. However, challenges remain. Catalytic mechanisms are not fully understood, selectivity is limited in complex samples, batch-to-batch reproducibility is poor, device integration is low, and clinical validation is lacking. Future work should focus on better design, standardized preparation, intelligent system integration, and multicenter clinical studies to promote their practical application in precision medicine, therapeutic drug monitoring, and public health.
No takes yet. Share an insight, caveat, or question.
Li et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: